CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-05 | Gallagher Cam Director | Grant or award · Stock Option (right to buy) | +52,825 | 52,825 | ||
| 2020-11-05 | Ainsworth Sean Director | Grant or award | +35,800 | 35,800 | ||
| 2020-11-05 | Ainsworth Sean Director | Grant or award · Stock Option (right to buy) | +35,663 | 35,663 | ||
| 2020-11-05 | Ainsworth Sean Director | Grant or award · Stock Option (right to buy) | +52,825 | 52,825 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award | +100,120 | 100,120 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award · Employee Stock Option (right to buy) | +42,867 | 42,867 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award · Employee Stock Option (right to buy) | +30,110 | 30,110 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award · Employee Stock Option (right to buy) | +4,226 | 4,226 | ||
| 2020-11-05 | Sooch Mina President and CEO | Grant or award | +788,520 | 788,520 | ||
| 2020-11-05 | Sooch Mina President and CEO | Grant or award · Employee Stock Option (right to buy) | +178,284 | 178,284 | ||
| 2020-11-05 | Sooch Mina President and CEO | Grant or award · Employee Stock Option (right to buy) | +158,475 | 158,475 | ||
| 2020-11-05 | Rodgers Richard J Director | Grant or award | +5,910 | 5,910 | ||
| 2019-06-06 | Cheong Kwang Soo Director | Grant or award · Stock Option (right to buy) | +3,537 | 3,537 | ||
| 2019-06-06 | Rodgers Richard J Director | Grant or award · Stock Option (right to buy) | +3,537 | 3,537 | ||
| 2019-06-06 | Sullivan Lara Director | Grant or award · Stock Option (right to buy) | +3,537 | 3,537 | ||
| 2019-06-06 | Brandt Peter C. Director | Grant or award · Stock Option (right to buy) | +3,537 | 3,537 | ||
| 2019-06-06 | Price Ben Gil Director | Grant or award · Stock Option (right to buy) | +3,537 | 3,537 | ||
| 2019-06-06 | Beever Charles Director | Grant or award · Stock Option (right to buy) | +3,537 | 3,537 | ||
| 2019-02-28 | Nolan Lisa Chief Business Officer | Option exercise | +1,625 | 23,250 | ||
| 2019-02-28 | Nolan Lisa Chief Business Officer | Option exercise · Restricted Stock Units | −1,625 | 3,250 |
Page 14 of 15 · 283 trades